SLXN · Silexion Therapeutics Corp · Executive Compensation
$0.26
0.00 (-0.73%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“our management has concluded that we do not have sufficient cash to fund our operations for 12 months from the issuance date of our consolidated financial statements for the three-month and six-month periods ended June 30, 2026 included in this quarterly report, but rather, under our current business plan, through the fourth quarter of 2026 and, as a result, there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$1.45M
Shares
5.56M
Volume · Oct 5
1.15M
Avg daily vol (3M)
9.82M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Ilan Hadar | Chief Executive Officer (formerly Managing Director of Silexion Israel) | $1,540,628 |
| Dr. Mitchell Shirvan | Chief Scientific and Development Officer | $1,301,490 |
| Mirit Horenshtein Hadar | Chief Financial Officer (formerly EVP Finance of Silexion Israel) | $770,090 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Ilan Hadar | Chief Executive Officer (formerly Managing Director of Silexion Israel) | $253,614 |
| Dr. Mitchell Shirvan | Chief Scientific and Development Officer | $206,800 |
| Mirit Horenshtein Hadar | Chief Financial Officer (formerly EVP Finance of Silexion Israel) | $26,238 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Amnon Peled | member of the Board | Resigned | 2026-07-31 |
| Ilan Levin | member of the Board | Terminated | 2026-03-25 |
| Amnon Peled | independent director | Appointed | 2024-12-10 |
| Ilan Shiloah | independent director serving on the board of directors | Resigned | 2024-09-19 |
| Shlomo Noy | Director | Appointed | 2024-08-21 |
| Ilan Shiloah | Director | Appointed | 2024-08-21 |
| Ilan Levin | Director | Appointed | 2024-08-21 |
| Avner Lushi | Director | Appointed | 2024-08-21 |
| Ruth Alon | Director | Appointed | 2024-08-21 |
| Dror Abramov | Director | Appointed | 2024-08-21 |
| Ilan Hadar | Chairman | Appointed | 2024-08-21 |
| Mitchell Shirvan | Chief Scientific and Development Officer | Appointed | 2024-08-21 |
| Mirit Horenshtein Hadar | Chief Financial Officer | Appointed | 2024-08-21 |
| Ilan Hadar | Chief Executive Officer | Appointed | 2024-08-21 |